Patents
We pride ourselves in running a patient-focused innovation program dedicated to advanced wound care and bleeding control. Our team is always exploring new opportunities and technologies to develop cutting-edge products and design new innovative solutions to improve patient care.
Are you interested in licensing Tricol Biomedical technology? Please contact us using the form on this page. Depending on the technology of interest, we can accommodate a range of licensing alternatives, including exclusive, non-exclusive, field of use and other limited licenses.
Tricol Biomedical HemCon® Bandage, HemCon® Gauze, HemCon® Dental Family & m.doc® Product Family Patents:
Patents
Country | Granted Patent |
---|---|
United States | 7482503 |
United States | 7820872 |
United States | 8269058 |
United States | 8313474 |
United States | 8668924 |
Netherlands | 1401352 |
Korea | 953465 |
Korea | 953466 |
Korea | 10-1105081 |
Korea | 10-1148248 |
Japan | 4332030 |
Japan | 4812630 |
Japan | 4854084 |
Israel | 159339 |
Israel | 184044 |
United Kingdom | EP1401352 |
United Kingdom | EP1704225 |
France | EP1401352 |
France | EP1704225 |
European Patent Office | 1401352 |
European Patent Office | 1704225 |
Germany | 1401352 |
Germany | 1704225 |
Canada | 2450668 |
Australia | 2002312493 |
Country Code | Granted Patent |
---|---|
US | 9,205,170 |
KR | 10-1548766 |
JP | 5726068 |
CN | 102076364 |
Country Code | Granted Patent |
---|---|
US | 7482503 |
US | 7820872 |
US | 7,897,832 |
US | 8269058 |
US | 8313474 |
US | 8668924 |
US | 9,004,918 |
NL | 1401352 |
KR | 953465 |
KR | 953466 |
KR | 10-1105081 |
KR | 10-1148248 |
KR | 10-1406566 |
JP | 4332030 |
JP | 4812630 |
JP | 4854084 |
JP | 5,474,351 |
IL | 159339 |
IL | 184044 |
GB | 1401352 |
GB | 1704225 |
FR | 1401352 |
FR | 1704225 |
EP | 1401352 |
EP | 1704225 |
DE | 1401352 |
DE | 1704225 |
CN | ZL200680047919.X |
CA | 2450668 |
AU | 2002312493 |
Country Code | Granted Patent | Note | Instructions |
---|---|---|---|
US | 6372196 | Applicable to m.doc spray only | |
US | 6372718 | ||
US | 8445671 | ||
US | 8865680 | Applicable to m.doc gel only | |
JP | 4362620 | ||
JP | 5331994 | ||
IT | 956305 | ||
IE | 82995 | ||
IE | 1919959 | ||
GB | 1919959 | ||
GB | 2335921 | ||
GB | 2575907 | Applicable to m.doc gel only | |
FR | 956305 | ||
FR | 1919959 | ||
FR | 2575907 | Applicable to m.doc gel only | |
EP | 2575907 | Applicable to m.doc gel only | |
EP | 956305 | ||
DE | 1919959 | ||
DE | 602011018244.7 | Applicable to m.doc gel only | |
DE | 69802666.7-08 | ||
CZ | 1919959 | ||
CA | 2279649 |
Tricol Biomedical Patent Families for Bioabsorbable, Biocompatible Chitosan; Percutaneous Vascular Injury Treatment Systems and Methods; Carbonic Acid Chitosan; Bioadhesive Chitosan Surgical Gel; and Superfine Chitosan Fiber can be found below:
Area | Patents |
---|---|
Biocompatible and Bioabsorbable Derivatized Chitosan Compositions | e.g., U.S. Patent Nos. 9,925,310, 9,547,011, and patents pending. |
Percutaneous vascular injury treatment systems and methods | e.g., PCT/US2016/012732, published as WO/2016/112342, and patents pending. |
Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field | e.g., PCT/US2016/026939, published as WO/2016/164903, and patents pending. |
Chitosan Superfine Fiber Systems | e.g., PCT/US17/17685, published as WO 2017/139775, and patents pending. |